Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Budget slips happen, but you can regain stability with a simple plan. Identify leaks, prioritize essentials, and set a realistic spending cap to regain confidence.
24,983 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Gas prices aren’t falling fast enough to ease drivers’ bills, prompting political action and a closer look at what dr...
Salesforce and Palantir posted strong quarters, but the market rewards or punishes them based on cash-return potentia...
Rising component costs revive a pricing debate for Apple. Analysts weigh whether the company should raise prices on i...
SpaceX's Starlink program could redefine internet access and investor value. This year’s launch pace hinges on regula...
VW's 100,000-job layoff plan signals a broader shift in auto manufacturing. As Chinese EVs tighten market share, inve...
In a wave of filings, multiple lawsuits claim hometap mischaracterized its HEI agreements and breached TILA, intensif...
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...
SoFi Technologies is navigating a volatile market as it heads into Q2 results, with analysts signaling potential upsi...
A new watchdog analysis shows lawmakers traded on information tied to pending votes, raising questions about ethics a...
As Netflix eyes growth beyond original programming, could this netflix's next move involve a strategic acquisition? T...
Palantir tops $300 billion in market value as Q1 2026 results reveal record growth and expanding margins. The milesto...